Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

January 18, 2024 21:00 ET | Source: Bragar Eagel & Squire

MILESTONE ALERT: Bragar Eagel & Squire, P.C. is Investigating Milestone Pharmaceuticals Inc. on Behalf of Milestone Stockholders and Encourages Investors to Contact the Firm

NEW YORK, Jan. 18, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, is investigating potential claims against Milestone Pharmaceuticals...
January 18, 2024 13:23 ET | Source: Block & Leviton LLP

Milestone Pharmaceuticals Investigated by Block & Leviton For Potential Securities Law Violations: Investors Who Have Lost Money Are Encouraged to Contact the Firm

BOSTON, Jan. 18, 2024 (GLOBE NEWSWIRE) -- Block & Leviton is investigating Milestone Pharmaceuticals, Inc. (NASDAQ: MIST) for potential securities law violations. Investors who have lost money...
January 06, 2024 15:59 ET | Source: The Rosen Law Firm PA

ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Milestone Pharmaceuticals Inc. Investors to Inquire About Securities Class Action Investigation – MIST

NEW YORK, Jan. 06, 2024 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Milestone...
January 01, 2024 12:35 ET | Source: The Rosen Law Firm PA

ROSEN, NATIONAL TRIAL LAWYERS, Encourages Milestone Pharmaceuticals Inc. Investors to Inquire About Securities Class Action Investigation – MIST

NEW YORK, Jan. 01, 2024 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of Milestone...
December 28, 2023 16:01 ET | Source: The Rosen Law Firm PA

MIST NEWS: ROSEN, A LEADING LAW FIRM, Encourages Milestone Pharmaceuticals Inc. Investors to Inquire About Securities Class Action Investigation – MIST

NEW YORK, Dec. 28, 2023 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of Milestone...
December 26, 2023 10:55 ET | Source: Block & Leviton LLP

Milestone Pharmaceuticals Investigated by Block & Leviton For Potential Securities Law Violations; Investors Who Have Lost Money Are Encouraged to Contact the Firm

BOSTON, Dec. 26, 2023 (GLOBE NEWSWIRE) -- Block & Leviton is investigating Milestone Pharmaceuticals, Inc. (NASDAQ: MIST) for potential securities law violations. Investors who have lost money...
December 11, 2021 21:00 ET | Source: KITA

Extraordinary Korean Products Presented at Tradekorea Homepage - Beauty & Fashion

CYPRESS, Calif., Dec. 11, 2021 (GLOBE NEWSWIRE) -- Korea International Trade Association (KITA) and the Ministry of SMEs and Startups (MSS) have decided to launch an online exhibition of innovative...
September 16, 2020 20:00 ET | Source: Juniper Networks

South Korea’s Airport Railroad Express Selects Juniper Networks’ AI-Driven Solutions to Build its All-IP Based Communications Network for Smarter and Safer Operations

SEOUL, Korea, Sept. 17, 2020 (GLOBE NEWSWIRE) -- Juniper Networks (NYSE: JNPR), a leader in secure, AI-driven networks, today announced that Airport Railroad Express (AREX), a commuter railway...
September 10, 2019 12:31 ET | Source: 650 Group

IoT and AI will Drive Further WLAN Growth; 802.11ax WLAN Infrastructure Market Shows 5% Y/Y Growth Following a Period of Acquisitions, According to 650 Group

PORTOLA VALLEY, Calif., Sept. 10, 2019 (GLOBE NEWSWIRE) -- A newly released report by 650 Group reveals 5% Y/Y revenue growth in the Enterprise plus Outdoor Wireless LAN market with a strong rebound...
June 12, 2019 22:00 ET | Source: Juniper Networks

Juniper Networks Wins “Best of Show” Top Awards at Interop Tokyo 2019

TOKYO, June 13, 2019 (GLOBE NEWSWIRE) -- Juniper Networks (NYSE:JNPR), an industry leader in automated, scalable and secure networks, today announced that it has been awarded multiple top honors at...

Next Page keyboard_arrow_right